Early vs delayed treatment with teriflunomide 14 mg results in reduced risk of disability progression in patients with MS

Authors
Category Primary study
JournalNeurology
Year 2016
This article has no abstract
Epistemonikos ID: e08801ef8846322541852182c915693310a9611e
First added on: Feb 07, 2025